CAS 868612-83-3

Formula: C25H20N6O

InChI: InChI=1S/C25H20N6O/c1-15-4-2-7-20(29-15)24-23(17-8-9-19-21(14-17)28-11-10-27-19)30-22(31-24)13-16-5-3-6-18(12-16)25(26)32/h2-12,14H,13H2,1H3,(H2,26,32)(H,30,31)

InChI key: RYKSGWSKILPDDY-UHFFFAOYSA-N

SMILES: CC1=NC(=CC=C1)C2=C(N=C(N2)CC3=CC(=CC=C3)C(=O)N)C4=CC5=NC=CN=C5C=C4

IN-1130

CAS: 868612-83-3

IN-1130

Formula: C₂₅H₂₀N₆O

Purity: 99.5%

Molecular weight: 420.47

Ref: 54-BUP10329

IN 1130

CAS: 868612-83-3

Formula: C₂₅H₂₀N₆O

Purity: 98%

Color and Shape: Solid

Molecular weight: 420.4659

Ref: IN-DA01E5KL

IN-1130

CAS: 868612-83-3

3-((5-(6-Methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide

Formula: C₂₅H₂₀N₆O

Purity: 98%

Molecular weight: 420.47

Ref: IN-DG01110186

IN 1130

Controlled Product

CAS: 868612-83-3

Formula: C₂₅H₂₀N₆O

Color and Shape: Neat

Molecular weight: 420.466

Ref: TR-I655855

IN 1130

CAS: 868612-83-3

IN 1130 is a molecule that has been shown to have antimicrobial effects against bacteria. It has been observed to inhibit the growth of prostate cancer cells, as well as decrease the disease activity of abdominal surgery patients. The mechanism of action is not fully understood, but it is hypothesized that IN 1130 is a growth factor-β1 agonist that inhibits the proliferation of tumor cells by binding to its receptor and activating intracellular signaling pathways. IN 1130 has also been shown to exhibit an effect on hematopoietic cells in vitro, with potential applications in pediatric and optical sensor technology. In addition, IN 1130 has been observed to be effective in treating cervical cancer with hydroxyl groups on the molecule that can react with histochemical stains.

Formula: C₂₅H₂₀N₆O

Purity: Min. 95%

Molecular weight: 420.47 g/mol

Ref: 3D-TJB61283

IN-1130

CAS: 868612-83-3

IN-1130: ALK5 inhibitor, IC50 - 5.3 nM (Smad3), 36 nM (casein), 4.3 μM (p38α MAPK).

Formula: C₂₅H₂₀N₆O

Purity: 99.79%

Color and Shape: Solid

Molecular weight: 420.4659

Ref: TM-T15572